All In Biotech

Drug Trial Radar · NCT07852728

HBOT Effects on First Responders' Cognition and Well-Being

Changes in Cognitive Functioning, Psychological Well-Being, and Quality of Life Following Hyperbaric Oxygen Therapy in First Responders

Last checked: Nov 20, 2026Latest source record: Oct 1, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

54

Planned (sponsor's estimate)

Start

Sep 11, 2026

Primary completion

Sep 11, 2027

Study completion Sep 11, 2027

Sponsor

Lead sponsor
Summit Hyperbarics and WellnessAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Oct 1, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The goal of this study is to examine changes in cognitive functioning and post-concussive symptoms following hyperbaric oxygen therapy (HBOT) in current and former first responders with a history of traumatic brain injury. The main questions it aims to answer are: 1. Do cognitive functioning and post-concussive symptoms change after 40 HBOT sessions? 2. Do symptoms of PTSD, depression, and anxiety, or quality of life, change after treatment? Approximately 54 participants will: * Complete medical and behavioral health screening. * Complete cognitive tests and questionnaires before and after treatment. * Receive 40 HBOT sessions at 2.0 atmospheres absolute (ATA), twice daily with at least four hours between sessions. All participants will receive HBOT. There is no comparison group, so the study cannot determine whether HBOT caused any observed changes.

Conditions

  • Traumatic Brain Injury
  • PTSD - Post Traumatic Stress Disorder
  • Anxiety
  • Depression
  • Post Concussion Symptoms

Interventions

  • Hyperbaric Oxygen Therapy (HBOT)Drug

    Participants in this arm will receive 40 hyperbaric oxygen therapy (HBOT) sessions at 2.0 atmospheres absolute (ATA). Sessions will occur twice daily, Monday through Friday, with at least four hours between sessions. Cognitive functioning, post-concussive symptoms, psychological symptoms, and quality of life will be assessed before and after treatment.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in NeuroTrax Global Cognitive ScoreTime frame: Baseline and after completion of 40 HBOT sessions (approximately 4 weeks).
  2. Change in Rivermead Post-Concussion Symptoms Questionnaire (RPQ) scoreTime frame: Baseline and after completion of 40 HBOT sessions (approximately 4 weeks).

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Summit Hyperbarics and Wellness

    Boise, Idaho · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.